The Spine PROMCO Study: a Cohort Observational Study

Sponsor
Park Medical centrum (Other)
Overall Status
Recruiting
CT.gov ID
NCT05963815
Collaborator
Erasmus Medical Center (Other)
4,000
1
84
47.6

Study Details

Study Description

Brief Summary

Our primary objective is to design a cohort to determine the treatment outcome of different surgical interventions of the degenerative lumbar spine highlighting the expediency and value of the current surgical treatment program.

Condition or Disease Intervention/Treatment Phase
  • Other: Spine surgery

Detailed Description

This observational prospective unicenter cohort study includes patients who are eligible for elective lumbar spine surgery due to a degenerative spine disease (e.g. herniated disk, spinal canal stenosis, discopathy and spondylolisthesis). We pursue an enrolment rate of at least 80% within 1.5 years of inclusion. A digital survey is used including self-reporting questionnaires that pertain to outcomes as pain, functionality and disability (COMI Back), health status (EQ-5D-5L), re-operations and complications, and satisfaction. The survey is sent at given time-intervals (e.g. baseline 2 weeks prior to surgery, 6 weeks post surgery and 6, 12, 36 months post surgery). Besides descriptive statistics and multivariate analysis, an economic evaluation will be performed from a societal perspective.

Study Design

Study Type:
Observational
Anticipated Enrollment :
4000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Spine Patient Reported Outcome Measures: a Cohort Observational Study
Actual Study Start Date :
Jan 13, 2023
Anticipated Primary Completion Date :
Jan 13, 2030
Anticipated Study Completion Date :
Jan 13, 2030

Arms and Interventions

Arm Intervention/Treatment
Degenerative spine disorder

Patients who are eligible for surgical treatment of the spine, including a lumbar herniated disk or lumbar spinal canal stenosis, discopathy and spondylolisthesis.

Other: Spine surgery
Patients operated with laminectomy, microscopic discectomy, percutaneous transforaminal endoscopic discectomy, and spondylodesis.

Outcome Measures

Primary Outcome Measures

  1. Patient related outcome Measures [Baseline preoperative (about 2 weeks pre surgery). After completing the baseline measurements, the patients are asked to repeat the survey post surgery on set dates; 6 weeks-6months-12months-24 months-and 36 months post surgery]

    PROMs will be collected using validated questionnaires that pertain to different domains: (1) pain intensity, (2) functionality, (3) disability, (4) health related quality of life, and (5) patient satisfaction. This prospective cohort study uses a set of outcome metrics in accordance with the ICHOMs recommendations for low back pain (cite). Including: COMI BACK, EQ5D5L

Secondary Outcome Measures

  1. Clinical outcome [post surgery on set dates; 6 weeks-6months-12months-24 months-and 36 months post surgery]

    Re-operation and complications are systematically assessed by self-reported questionnaires (e.g. liquor leakage, sensomotoric deficits, incontinence, infections, etc).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All patients who are eligible for elective surgery of the lumbar spine.

  • All patients with degenerative disorder of the lumbar spine including: herniated disk, stenosis, discopathy and spondylolisthesis.

  • Patients must be able to fill in the questionnaire online

  • Patients with imaging (Magnetic resonance imaging (MRI)) confirmed lumbar disc herniation, stenosis, discopathy, or listhesis.

  • Elective cases

  • Patients operated with laminectomy, microscopic discectomy, percutaneous transforaminal endoscopic discectomy, and spondylodesis.

Exclusion Criteria:
  • Patients who cannot speak nor read the Dutch language

  • Patients who are not able to complete the digital questionnaires, according to the including doctor

  • Patients with fractures, primary infections of the spine, or with spinal malignant- cies.

  • Patients in a traumatic setting.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Park Medical Center Rotterdam Zuid-Holland Netherlands 30677 GH

Sponsors and Collaborators

  • Park Medical centrum
  • Erasmus Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Park Medical centrum
ClinicalTrials.gov Identifier:
NCT05963815
Other Study ID Numbers:
  • 0000090
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Park Medical centrum
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023